{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:02:44Z","timestamp":1790820164618,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2022\/13216-0"],"award-info":[{"award-number":["2022\/13216-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011875","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia, Inova\u00e7\u00f5es e Comunica\u00e7\u00f5es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006416","name":"Universidade Estadual de Campinas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006417","name":"State University of Campinas Teaching Research and Extension Support Fund","doi-asserted-by":"publisher","award":["2023\/04157-3"],"award-info":[{"award-number":["2023\/04157-3"]}],"id":[{"id":"10.13039\/501100006417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["308452\/2021-6"],"award-info":[{"award-number":["308452\/2021-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtha.2025.06.010","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T19:43:01Z","timestamp":1749843781000},"page":"3208-3219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of phenotypes in thrombotic primary antiphospholipid syndrome using cluster analysis: a step toward personalized medicine"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9478-176X","authenticated-orcid":false,"given":"Gabrielle M.","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Or","family":"Hen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Ontiveros\u2013Austria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotem","family":"Liran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rodriguez\u2013Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Cerchiari de God\u00f3i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonatan Shneor","family":"Patt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaked","family":"Beladev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Collela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Stefanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela G.","family":"Yamaguti\u2013Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Annichino\u2013Bizzachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Vargas\u2013Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Prestes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich V.","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ophira","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Demichelis\u2013Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Barrera\u2013Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Villa\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7908-9073","authenticated-orcid":false,"given":"Fernanda A.","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.06.010_bib1","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2025.06.010_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.010_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.thromres.2020.10.010","article-title":"Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management","volume":"198","author":"Sayar","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.06.010_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtha.2025.06.010_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112819","article-title":"Differences in antiphospholipid antibody profile between patients with obstetric and thrombotic antiphospholipid syndrome","volume":"23","author":"Anunciaci\u00f3n\u2013Llunell","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.06.010_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.semarthrit.2019.04.009","article-title":"The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: eesults from the APS ACTION cohort","volume":"49","author":"Radin","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jtha.2025.06.010_bib7","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1111\/j.1538-7836.2005.01359.x","article-title":"Pathophysiology of the antiphospholipid syndrome","volume":"3","author":"de Groot","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.010_bib8","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/jth.14936","article-title":"Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: a systematic review and meta-analysis","volume":"18","author":"Ortel","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.010_bib9","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1182\/bloodadvances.2017008185","article-title":"Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking. Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy","volume":"1","author":"Jackson","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.06.010_bib10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/rheumatology\/keab410","article-title":"Effect of statins on the prevention of recurrent thrombosis in thrombotic antiphospholipid syndrome","volume":"61","author":"Kwon","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtha.2025.06.010_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12026-016-8812-z","article-title":"Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome","volume":"65","author":"Nuri","year":"2017","journal-title":"Immunol Res"},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2025.06.010_bib12","first-page":"S20","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtha.2025.06.010_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/HJH.0000000000003563","article-title":"Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension","volume":"42","author":"Charchar","year":"2024","journal-title":"J Hypertens"},{"issue":"Suppl 2","key":"10.1016\/j.jtha.2025.06.010_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jtha.2025.06.010_bib15","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.010_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2021.103788","article-title":"Simulation-derived best practices for clustering clinical data","volume":"118","author":"Coombes","year":"2021","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jtha.2025.06.010_bib17","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/rheumatology\/keac548","article-title":"Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases","volume":"62","author":"Nguyen","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtha.2025.06.010_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1361062","article-title":"Four clinical and biological phenotypes in antiphospholipid syndrome: a cluster analysis of 174 patients with antinuclear antibody tests","volume":"15","author":"Ottavi","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2025.06.010_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002881","article-title":"Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study","volume":"9","author":"Guedon","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.jtha.2025.06.010_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103173","article-title":"Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases","volume":"144","author":"Taieb","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jtha.2025.06.010_bib21","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1007\/s10238-023-01195-x","article-title":"Cluster analysis of antiphospholipid antibodies-associated adverse pregnancy outcome patients: based on a 13-years cohort study","volume":"23","author":"Long","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jtha.2025.06.010_bib22","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1177\/0961203320940776","article-title":"Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry","volume":"29","author":"Zuily","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.jtha.2025.06.010_bib23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtha.2025.06.010_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2020004942","article-title":"How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome","volume":"137","author":"Cohen","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.06.010_bib25","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1055\/s-0038-1650686","article-title":"Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies","volume":"76","author":"Horbach","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.010_bib26","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1177\/09612033241266989","article-title":"Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: a single centre retrospective study","volume":"33","author":"Mittal","year":"2024","journal-title":"Lupus"},{"key":"10.1016\/j.jtha.2025.06.010_bib27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2013.11.004","article-title":"Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis","volume":"13","author":"Reynaud","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtha.2025.06.010_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102813","article-title":"Cardiovascular disease risk in antiphospholipid syndrome: thrombo-inflammation and atherothrombosis","volume":"128","author":"Tektonidou","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jtha.2025.06.010_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.thromres.2013.11.012","article-title":"Risk factors for arterial thrombosis in antiphospholipid syndrome","volume":"133","author":"Matyja\u2013Bednarczyk","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.06.010_bib30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","article-title":"Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis","volume":"117","author":"Ginsburg","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.06.010_bib31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1046\/j.1365-2141.2002.03949.x","article-title":"Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study","volume":"119","author":"Runchey","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.06.010_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1538-7836.2005.01691.x","article-title":"A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)","volume":"4","author":"Naess","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.010_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","article-title":"Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy","volume":"104","author":"Schulman","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2025.06.010_bib34","first-page":"382","article-title":"The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome","volume":"31","author":"Hern\u00e1ndez\u2013Molina","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jtha.2025.06.010_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.010_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002534","article-title":"Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study","volume":"9","author":"Laurent","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.jtha.2025.06.010_bib37","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/ajh.24875","article-title":"The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome","volume":"92","author":"da Silva Saraiva","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2025.06.010_bib38","first-page":"926","article-title":"Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?","volume":"31","author":"Berman","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jtha.2025.06.010_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11239-009-0356-9","article-title":"The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome","volume":"29","author":"Diz\u2013Kucukkaya","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.06.010_bib40","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1182\/blood-2017-09-805689","article-title":"Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism","volume":"131","author":"Kearon","year":"2018","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625003939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625003939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:25:56Z","timestamp":1790817956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625003939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1538783625003939"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.06.010","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of phenotypes in thrombotic primary antiphospholipid syndrome using cluster analysis: a step toward personalized medicine","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}